IVI RMA North America, a leader in fertility care and assisted reproduction, will deliver 36 presentations and poster ...
Phase 1 data of first-in-class NBD1 stabilizers, SION-719 and SION-451, demonstrated they were generally well tolerated and exceeded desired ...
Phase 1 data of first-in-class NBD1 stabilizers, SION-719 and SION-451, demonstrated they were generally well tolerated and exceeded desired pharmacokinetic targets ...
Spyre Therapeutics is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and ...
The Ghana Armed Forces Health Services officially opened the second edition of the Scientific Conference, to commence ...
Menopause brings profound shifts not just in hormones but in the very structure of the brain. Scientists have found that gray ...
Company studies continue to show durability and retention of benefits for patients receiving proximal hypoglossal nerve stimulation for moderate to severe obstructive sleep apnea LivaNova PLC (Nasdaq: ...
Company studies continue to show durability and retention of benefits for patients receiving proximal hypoglossal nerve stimulation for moderate to severe obstructive sleep apnea LONDON, October 07, ...
Late-breaking poster presenters will have the opportunity to upload a virtual poster PDF and/or present their poster in person in San Diego. Review the rules and FAQs for more information. An ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback